Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Medtronic
Cerilliant
US Army
Farmers Insurance
Covington
Fish and Richardson
Fuji
Mallinckrodt

Generated: January 18, 2018

DrugPatentWatch Database Preview

PARAPLATIN Drug Profile

« Back to Dashboard

Which patents cover Paraplatin, and when can generic versions of Paraplatin launch?

Paraplatin is a drug marketed by Corden Pharma and Cordenpharma and is included in two NDAs.

The generic ingredient in PARAPLATIN is carboplatin. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the carboplatin profile page.
Drug patent expirations by year for PARAPLATIN
Medical Subject Heading (MeSH) Categories for PARAPLATIN

US Patents and Regulatory Information for PARAPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-004 Jan 15, 2004 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-001 Jul 14, 2003 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-003 Mar 3, 1989 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-003 Jul 14, 2003 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-002 Jul 14, 2003 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PARAPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-002 Jul 14, 2003 ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-003 Jul 14, 2003 ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-001 Jul 14, 2003 ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-003 Mar 3, 1989 ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-004 Jan 15, 2004 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Cerilliant
Dow
Deloitte
UBS
Queensland Health
Covington
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot